Lipid-lowering therapies: Better together

被引：26

作者：

Banach, Maciej ^{[1
,2
,3
]}

Penson, Peter E. ^{[4
,5
]}

机构：

[1] Med Univ Lodz MUL, Dept Hypertens, Lodz, Poland

[2] Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland

[3] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland

[4] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool, Merseyside, England

[5] Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England

来源：

ATHEROSCLEROSIS | 2021年 / 320卷

关键词：

Bempedoic acid; Combination therapy; Lipid-lowering therapy; Statins; STATIN INTOLERANCE; POSITION PAPER;

D O I：

10.1016/j.atherosclerosis.2021.01.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：86 / 88

页数：3

共 22 条

[1] Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to Go [J].

Banach, Maciej ;

Penson, Peter E. .

JAMA NETWORK OPEN, 2020, 3 (11)

[2] Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia [J].

Banach, Maciej ;

Duell, P. Barton ;

Gotto, Antonio M., Jr. ;

Laufs, Ulrich ;

Leiter, Lawrence A. ;

Mancini, G. B. John ;

Ray, Kausik K. ;

Flaim, JoAnn ;

Ye, Zhan ;

Catapano, Alberico L. .

JAMA CARDIOLOGY, 2020, 5 (10) :1124-1135

[3] What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? [J].

Banach, Maciej ;

Penson, Peter E. .

CARDIOVASCULAR RESEARCH, 2019, 115 (03) :E26-E31

[4] Statin Intolerance Some Practical Hints [J].

Banach, Maciej ;

Mikhailidis, Dimitri P. .

CARDIOLOGY CLINICS, 2018, 36 (02) :225-231

[5] Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel [J].

Banach, Maciej ;

Rizzo, Manfredi ;

Toth, Peter P. ;

Farnier, Michel ;

Davidson, Michael H. ;

Al-Rasadi, Khalid ;

Aronow, Wilbert S. ;

Athyros, Vasilis ;

Djuric, Dragan M. ;

Ezhov, Marat V. ;

Greenfield, Robert S. ;

Hovingh, G. Kees ;

Kostner, Karam ;

Serban, Corina ;

Lighezan, Daniel ;

Fras, Zlatko ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Goudev, Assen ;

Ceska, Richard ;

Nicholls, Stephen J. ;

Broncel, Marlena ;

Nikolic, Dragana ;

Pella, Daniel ;

Puri, Raman ;

Rysz, Jacek ;

Wong, Nathan D. ;

Bajnok, Laszlo ;

Jones, Steven R. ;

Ray, Kausik K. ;

Mikhailidis, Dimitri P. .

ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) :1-23

[6] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].

Cannon, Christopher P. ;

Blazing, Michael A. ;

Giugliano, Robert P. ;

McCagg, Amy ;

White, Jennifer A. ;

Theroux, Pierre ;

Darius, Harald ;

Lewis, Basil S. ;

Ophuis, Ton Oude ;

Jukema, J. Wouter ;

De Ferrari, Gaetano M. ;

Ruzyllo, Witold ;

De Lucca, Paul ;

Im, KyungAh ;

Bohula, Erin A. ;

Reist, Craig ;

Wiviott, Stephen D. ;

Tershakovec, Andrew M. ;

Musliner, Thomas A. ;

Braunwald, Eugene ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397

[7] Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis [J].

Cicero, Arrigo F. G. ;

Fogacci, Federica ;

Hernandez, Adrian V. ;

Banach, Maciej .

PLOS MEDICINE, 2020, 17 (07)

[8] Interpretation of the evidence for the efficacy and safety of statin therapy [J].

Collins, Rory ;

Reith, Christina ;

Emberson, Jonathan ;

Armitage, Jane ;

Baigent, Colin ;

Blackwell, Lisa ;

Blumenthal, Roger ;

Danesh, John ;

Smith, George Davey ;

DeMets, David ;

Evans, Stephen ;

Law, Malcolm ;

MacMahon, Stephen ;

Martin, Seth ;

Neal, Bruce ;

Poulter, Neil ;

Preiss, David ;

Ridker, Paul ;

Roberts, Ian ;

Rodgers, Anthony ;

Sandercock, Peter ;

Schulz, Kenneth ;

Sever, Peter ;

Simes, John ;

Smeeth, Liam ;

Wald, Nicholas ;

Yusuf, Salim ;

Peto, Richard .

LANCET, 2016, 388 (10059) :2532-2561

[9] How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors [J].

Cybulska, Barbara ;

Klosiewicz-Latoszek, Longina ;

Penson, Peter E. ;

Nabavi, Seyed Mohammad ;

Lavie, Carl J. ;

Banach, Maciej .

PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 67 :65-74

[10] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel [J].

Ference, Brian A. ;

Ginsberg, Henry N. ;

Graham, Ian ;

Ray, Kausik K. ;

Packard, Chris J. ;

Bruckert, Eric ;

Hegele, Robert A. ;

Krauss, Ronald M. ;

Raal, Frederick J. ;

Schunkert, Heribert ;

Watts, Gerald F. ;

Boren, Jan ;

Fazio, Sergio ;

Horton, Jay D. ;

Masana, Luis ;

Nicholls, Stephen J. ;

Nordestgaard, Borge G. ;

van de Sluis, Bart ;

Taskinen, Marja-Riitta ;

Tokgozoglu, Lale ;

Landmesser, Ulf ;

Laufs, Ulrich ;

Wiklund, Olov ;

Stock, Jane K. ;

Chapman, M. John ;

Catapano, Alberico L. .

EUROPEAN HEART JOURNAL, 2017, 38 (32) :2459-2472

← 1 2 3 →